HAMBURG, Germany, Dec. 13, 2024 (GLOBE NEWSWIRE) — XCHG Limited (“XCharge” or the “Company”), (NASDAQ: XCH), a global leader in integrated EV charging solutions, today announced its unaudited financial results for the three months ended June 30, 2024.
Operational Highlights
| Three months ended June 30, 2024 | Six months ended June 30, 2024 | ||
| DC fast charger deliveries | 438 | 764 | |
| NZS charger deliveries | 26 | 51 | |
| Total EV charger deliveries | 619 | 1,155 | |
- Q2 2024 DC fast charger deliveries were 438, representing a decrease of 31.8% from 642 in the corresponding period of 2023.
- Q2 2024 Total EV charger deliveries were 619, representing a decrease of 5.4% from 654 in the corresponding period of 2023.
- DC fast charger deliveries in the first six months of 2024 were 764, representing a decrease of 30.0% from 1,092 in the corresponding period of 2023.
- Total EV charger deliveries in the first six months of 2024 were 1,155, representing an increase of 2.1% from 1,131 in the corresponding period of 2023.
Management Remarks
Mr. Yifei Hou, Chief Executive Officer of XCharge, commented, “We are pleased to achieve a resilient operating performance in the second quarter of 2024 despite the challenging macroeconomic environment. In this quarter, as we strove to meet customer demands and strengthen our leading position in the global industry, we delivered 26 Net Zero Series (“NZS”) chargers, representing substantial growth from the prior year, which brought our total NZS charger deliveries up to 51 for the first half of 2024. As a pioneer in the EV charger market, we are committed to enhancing our cutting-edge technologies and developing creative solutions to tackle energy problems, innovatively meeting our clients’ needs. Looking ahead, we will continue to invest in research and development, creating new commercialization opportunities and building a global green future.”
Initial Public Offering (“IPO”)
In September, the Company successfully completed its initial public offering of 3,462,223 American depositary shares (“ADSs”) at a price of US$6.20 per ADS, including 128,888 ADSs that the underwriter partially exercised over-allotment options. Each ADS represents 40 Class A ordinary shares. The total offering size was approximately US$21.5 million before deducting the underwriting discounts and commissions and relevant expenses, with net proceeds of US$19.1 million.
Financial Highlights for the Second Quarter of 2024
(in USD millions, except for per ordinary share data and percentage)
| Q2 2024 | Q2 2023 | % Change1 | ||||
| Revenues | 9.0 | 12.2 | (26.3) | |||
| Gross profit | 4.2 | 5.5 | (23.9) | |||
| Gross margin | 46.1% | 44.7% | 1.4 | |||
| Operating (loss)/income | (0.9) | 2.1 | (144.9) | |||
| Net (loss)/income | (1.0) | 2.0 | (146.8) | |||
| Adjusted2 net (loss)/income | (0.9) | 2.0 | (146.0) | |||
| Net (loss)/income attributable to ordinary shareholders | (1.3) | 0.5 | (390.6) | |||
| (Loss) /earnings per ordinary share-basic and diluted | (0.002) | 0.001 | (336.5) |
__________________________________________
1 Except for gross margin, where absolute change instead of percentage change is presented.
2 See “Use of Non-GAAP Financial Measures” and “Unaudited Reconciliation of GAAP and Non-GAAP Results” included in this release for further details.
- Revenues were US$9.0 million for the second quarter of 2024, representing a decrease of 26.3% from US$12.2 million for the same period of 2023. Product revenues were US$8.9 million for the second quarter of 2024, representing a decrease of 26.7% from US$12.1 million for the same period of 2023. The year-over-year decrease was mainly due to the decrease in deliveries to a major customer in Europe. Service revenues were US$0.1 million for the second quarter of 2024, representing an increase of 50% from US$0.1 million for the same period of 2023. The year-over-year increase was mainly due to the increase in maintenance services revenue.
- Cost of revenues was US$4.8 million for the second quarter of 2024, representing a decrease of 28.2% from US$6.7 million for the same period of 2023. The year-over-year decrease was mainly due to the decrease in revenue.
- Gross margin was 46.1% for the second quarter of 2024, compared with 44.7% for the same period of 2023. The year-over-year increase was mainly due to our enhanced cost control measures.
- Selling and marketing expenses were US$2.3 million for the second quarter of 2024, representing an increase of 74.2% from US$1.3 million for the same period of 2023.The year-over-year increase was mainly due to increases in staff costs, sales commissions and advertising expenses for business expansion.
- Research and development expenses were US$1.2 million for the second quarter of 2024, representing an increase of 18.7% from US$1.0 million for the same period of 2023. The year-over-year increase was mainly due to the increase in staff costs for researching and developing new products.
- General and administrative expenses were US$1.6 million for the second quarter of 2024, representing an increase of 47.4% from US$1.1 million for the same period of 2023. The year-over-year increase was mainly due to increases in staff costs, tax expenses and professional service expenses.
- Operating (loss)/income was US$(0.9) million for the second quarter of 2024, compared with US$2.1 million for the same period of 2023.
- Net (loss)/income was US$(1.0) million for the second quarter of 2024, compared with US$2.0 million for the same period of 2023. Excluding changes in fair value of financial instruments and gain on extinguishment of convertible debt, adjusted net income (loss) was US$(0.9) million for the second quarter of 2024, compared with US$2.0 million for the same period of 2023.
- Net (loss)/income attributable to ordinary shareholders was US$(1.3) million for the second quarter of 2024, compared with US$0.5 million for the same period of 2023.
- Basic and diluted (loss) /earnings per ordinary share was US$(0.002) for the second quarter of 2024, compared with US$0.001 for the same period of 2023.
- Cash and cash equivalents were US$24.3 million as of June 30, 2024, compared with US$12.8 million as of March 31, 2024.
About XCharge
XCharge, founded in 2015, is a global leader in integrated EV charging solutions. The Company offers comprehensive EV charging solutions which primarily include the DC fast chargers, the advanced battery-integrated DC fast chargers, as well as its accompanying services. Through the combination of XCharge’s proprietary charging technology, energy storage system technology, and accompanying services, the Company enhances EV charging efficiency and unlocks the value of energy storage and management. Committed to providing innovative and efficient EV charging solutions, XCharge is actively working towards establishing a global green future that is critical to long-term growth and development.
For more information, please visit: https://investors.xcharge.com/
Use of Non-GAAP Financial Measures
We consider adjusted net income (loss), a non-GAAP financial measure as a supplemental measure to review and assess our operating performance. The presentation of this non-GAAP financial measure is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. We present this non-GAAP financial measure because it is used by our management to evaluate our operating performance and formulate business plans. We also believe that the use of this non-GAAP measure facilitates investors’ assessment of our operating performance.
This non-GAAP financial measure is not defined under U.S. GAAP and is not presented in accordance with U.S. GAAP. This non-GAAP financial measure has limitations as an analytical tool. One of the key limitations of using this non-GAAP financial measure is that it does not reflect all items of income and expense that affect our operations. Further, this non-GAAP measure may differ from the non-GAAP information used by other companies, including peer companies, and therefore its comparability may be limited. We compensate for these limitations by reconciling this non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating our performance. We encourage you to review our financial information in its entirety and not rely on a single financial measure.
We define adjusted net income (loss) as net income (loss) excluding changes in fair value of financial instruments and gain on extinguishment of convertible debt. For more information on these non-GAAP financial measures, please see the tables captioned “Unaudited Reconciliations of GAAP and Non-GAAP Results” set forth at the end of this release.
Exchange Rate Information
This announcement contains translations of certain EUR amounts into U.S. dollars and RMB amounts into U.S. dollars at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from EUR to U.S. dollars, from U.S. dollars to EUR, from RMB to U.S. dollars and from U.S. dollars to RMB are made at EUR1.0711 to US$1.00 and RMB7.2672 to US$1.00, the exchange rates on June 28, 2024, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that any amounts that could have been, or could be, converted into another currency, as the case may be, at any particular rate or at all.
Safe Harbor Statement
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to”, or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.
For investor and media inquiries, please contact:
XCharge
IR Department
Email: ir@xcharge.com
Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
Jenny Cai
Tel: +86 (10) 6508-0677
Email: XCharge@tpg-ir.com
Source: XCHG Limited
| XCHG LIMITED UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
| As of December 31, | As of June 30, | |||||
| 2023 | 2024 | |||||
| US$ | US$ | |||||
| ASSETS | ||||||
| Current assets | ||||||
| Cash and cash equivalents | 15,660,786 | 24,258,144 | ||||
| Restricted cash | 32,024 | 31,048 | ||||
| Accounts receivable, net | 12,495,375 | 4,722,863 | ||||
| Amounts due from related parties | 1,671,220 | 1,355,893 | ||||
| Inventories | 6,656,708 | 7,481,488 | ||||
| Prepayments and other current assets | 3,228,984 | 3,349,664 | ||||
| Total current assets | 39,745,097 | 41,199,100 | ||||
| Non‑current assets | ||||||
| Property and equipment, net | 576,376 | 721,540 | ||||
| Intangible assets, net | 27,130 | 12,256 | ||||
| Long-term investments | 105,892 | 105,237 | ||||
| Operating lease right-of-use assets, net | 505,417 | 1,967,458 | ||||
| Total non‑current assets | 1,214,815 | 2,806,491 | ||||
| Total assets | 40,959,912 | 44,005,591 | ||||
| LIABILITIES | ||||||
| Current liabilities | ||||||
| Short-term borrowings | 5,560,027 | 8,887,761 | ||||
| Accounts payable | 5,750,157 | 5,686,213 | ||||
| Contract liabilities | 1,332,132 | 2,751,296 | ||||
| Operating lease liabilities—current | 294,028 | 618,793 | ||||
| Convertible debts | 12,516,331 | – | ||||
| Financial liability | 247,265 | 518,260 | ||||
| Accrued expenses and other current liabilities | 5,027,620 | 4,803,217 | ||||
| Total current liabilities | 30,727,560 | 23,265,540 | ||||
| Non‑current liabilities | ||||||
| Operating lease liabilities—non-current | 172,070 | 1,176,438 | ||||
| Other non-current liabilities | 79,964 | 116,287 | ||||
| Total non‑current liabilities | 252,034 | 1,292,725 | ||||
| Total liabilities | 30,979,594 | 24,558,265 | ||||
| XCHG LIMITED UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
| As of December 31, | As of June 30, | |||||
| 2023 | 2024 | |||||
| US$ | US$ | |||||
| Commitment and contingencies | – | – | ||||
| Mezzanine equity | ||||||
| Series Angel preference shares (US$0.00001 par value; 37,500,000 shares authorized, issued and outstanding as of December 31, 2023 and June 30, 2024. Liquidation preference of US$1,200,107 and US$1,192,681 as of December 31, 2023 and June 30, 2024) | 1,176,340 | 1,176,340 | ||||
| Series Angel redeemable preference shares (US$0.00001 par value; 37,500,000 shares authorized, issued and outstanding as of December 31, 2023 and June 30, 2024. Redemption value of US$1,200,107 and US$1,192,681 as of December 31, 2023 and June 30, 2024; Liquidation preference of US$1,200,107 and US$1,192,681 as of December 31, 2023 and June 30, 2024) | 1,176,340 | 1,176,340 | ||||
| Series A redeemable preference shares (US$0.00001 par value; 300,000,000 shares authorized, issued and outstanding as of December 31, 2023 and June 30, 2024. Redemption value of US$8,043,015 and US$8,292,329 as of December 31, 2023 and June 30, 2024; Liquidation preference of US$7,500,000 and US$7,500,000 as of December 31, 2023 and June 30, 2024) | 8,043,015 | 8,292,329 | ||||
| Series A+ redeemable preference shares (US$0.00001 par value; 118,971,900 shares authorized, issued and outstanding as of December 31, 2023 and June 30, 2024. Redemption value of US$3,732,918 and US$3,602,251 as of December 31, 2023 and June 30, 2024; Liquidation preference of US$3,720,623 and US$3,703,251 as of December 31, 2023 and June 30, 2024) | 3,795,370 | 3,795,370 | ||||
| Series B redeemable preference shares (US$0.00001 par value; 602,372,700 shares authorized, issued and outstanding as of December 31, 2023 and June 30, 2024. Redemption value of US$23,253,627 and US$23,597,312 as of December 31, 2023 and June 30, 2024; Liquidation preference of US$19,286,070 and US$19,252,636 as of December 31, 2023 and June 30, 2024) | 25,825,948 | 26,248,252 | ||||
| Series B+ redeemable preference shares (US$0.00001 par value; 204,195,160 shares authorized, nil and 161,977,511 shares issued and outstanding as of December 31, 2023 and June 30, 2024. Redemption value of nil and US$9,547,792 as of December 31, 2023 and June 30, 2024; Liquidation preference of nil and US$9,120,503 as of December 31, 2023 and June 30, 2024) | – | 9,720,793 | ||||
| Total mezzanine equity | 40,017,013 | 50,409,424 | ||||
| SHAREHOLDERS’ DEFICIT | ||||||
| Ordinary shares (USD0.00001 par value, 3,728,605,400 shares authorized, 806,200,500 shares issued and outstanding as of December 31, 2023 and June 30, 2024) | 8,062 | 8,062 | ||||
| Series Seed preference shares (US$0.00001 par value; 175,050,000 shares authorized, issued and outstanding as of December 31, 2023 and June 20, 2024) | 2,000,000 | 2,000,000 | ||||
| Additional paid-in capital | 6,563,764 | 5,822,913 | ||||
| Accumulated other comprehensive income | 1,824,365 | 1,858,054 | ||||
| Accumulated deficit | (40,432,886) | (40,651,127) | ||||
| Total shareholders’ deficit | (30,036,695) | (30,962,098) | ||||
| Total liabilities, mezzanine equity and shareholders’ deficit | 40,959,912 | 44,005,591 | ||||
| XCHG LIMITED UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) | ||||||
| For the Three Months Ended | ||||||
| June 30, | ||||||
| 2023 | 2024 | |||||
| US$ | US$ | |||||
| Revenues | 12,204,385 | 8,997,506 | ||||
| Cost of revenues | (6,748,376) | (4,845,198) | ||||
| Gross profit | 5,456,009 | 4,152,308 | ||||
| Operating expenses | ||||||
| Selling and marketing expenses | (1,291,521) | (2,250,336) | ||||
| Research and development expenses | (992,085) | (1,178,086) | ||||
| General and administrative expenses | (1,117,020) | (1,646,991) | ||||
| Total operating expenses | (3,400,626) | (5,075,413) | ||||
| Government grants | – | 104 | ||||
| Operating income (loss) | 2,055,383 | (923,001) | ||||
| Changes in fair value of financial instruments | (16,412) | (256,771) | ||||
| Gain on extinguishment of convertible debt | – | 247,283 | ||||
| Interest expenses | (37,316) | (71,363) | ||||
| Interest income | 31,268 | 52,693 | ||||
| Income (loss) before income taxes | 2,032,923 | (951,159) | ||||
| Income tax expense | – | – | ||||
| Net income (loss) | 2,032,923 | (951,159) | ||||
| Accretion of redeemable preference shares to redemption value | (698,646) | (368,607) | ||||
| Undistributed earnings attributable to redeemable preferred shareholders and Series Seed preferred shareholders of the Company | (880,056) | – | ||||
| Net income (loss) attributable to ordinary shareholders | 454,221 | (1,319,766) | ||||
| Net income (loss) | 2,032,923 | (951,159) | ||||
| Other comprehensive loss | ||||||
| Foreign currency translation adjustment, net of nil income taxes | 1,774,143 | 53,874 | ||||
| Total comprehensive income (loss) | 3,807,066 | (897,285) | ||||
| Earnings (loss) per ordinary share | ||||||
| – Basic and diluted | 0.001 | (0.002) | ||||
| Weighted average shares outstanding used in calculating basic and diluted earnings per share ordinary share | ||||||
| – Basic and diluted | 656,200,500 | 806,200,500 | ||||
| XCHG LIMITED UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) | ||||||
| For the Six Months Ended | ||||||
| June 30, | ||||||
| 2023 | 2024 | |||||
| US$ | US$ | |||||
| Revenues | 19,589,628 | 20,149,953 | ||||
| Cost of revenues | (11,038,743) | (10,332,829) | ||||
| Gross profit | 8,550,885 | 9,817,124 | ||||
| Operating expenses | ||||||
| Selling and marketing expenses | (2,460,884) | (4,379,024) | ||||
| Research and development expenses | (1,734,157) | (2,165,705) | ||||
| General and administrative expenses | (2,088,247) | (3,307,565) | ||||
| Total operating expenses | (6,283,288) | (9,852,294) | ||||
| Government grants | 2,367 | 31,206 | ||||
| Operating income (loss) | 2,269,964 | (3,964) | ||||
| Changes in fair value of financial instruments | (16,819) | (416,109) | ||||
| Gain on extinguishment of convertible debt | – | 247,283 | ||||
| Interest expenses | (73,810) | (115,156) | ||||
| Interest income | 52,028 | 81,003 | ||||
| Income (loss) before income taxes | 2,231,363 | (206,943) | ||||
| Income tax expense | – | (11,298) | ||||
| Net income (loss) | 2,231,363 | (218,241) | ||||
| Accretion of redeemable preference shares to redemption value | (1,019,628) | (740,852) | ||||
| Undistributed earnings attributable to redeemable preferred shareholders and Series Seed preferred shareholders of the Company | (799,231) | – | ||||
| Net income (loss) attributable to ordinary shareholders | 412,504 | (959,093) | ||||
| Net income (loss) | 2,231,363 | (218,241) | ||||
| Other comprehensive loss | ||||||
| Foreign currency translation adjustments | 956,545 | 33,689 | ||||
| Total comprehensive income (loss) | 3,187,908 | (184,552) | ||||
| Earnings (loss) per ordinary share | ||||||
| – Basic and diluted | 0.001 | (0.001) | ||||
| Weighted average shares outstanding used in calculating basic and diluted earnings per share ordinary shares | ||||||
| – Basic and diluted | 656,200,500 | 806,200,500 | ||||
| XCHG LIMITED UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS | ||||||
| For the Three Months Ended | ||||||
| June 30, | ||||||
| 2023 | 2024 | |||||
| US$ | US$ | |||||
| Net income (loss) | 2,032,923 | (951,159) | ||||
| Add: | ||||||
| Changes in fair value of financial instruments | 16,412 | 256,771 | ||||
| Gain on extinguishment of convertible debt | – | (247,283) | ||||
| Non-GAAP net income (loss) | 2,049,335 | (941,671) | ||||
| Earnings (loss) per ordinary share | ||||||
| – Basic and diluted | 0.001 | (0.002) | ||||
| Add: | ||||||
| Changes in fair value of financial instruments | – | – | ||||
| Gain on extinguishment of convertible debt | – | – | ||||
| Non-GAAP earnings (loss) per ordinary share – basic and diluted | 0.001 | (0.002) | ||||
| XCHG LIMITED UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS | ||||||
| For the Six Months Ended | ||||||
| June 30, | ||||||
| 2023 | 2024 | |||||
| US$ | US$ | |||||
| Net income (loss) | 2,231,363 | (218,241) | ||||
| Add: | ||||||
| Changes in fair value of financial instruments | 16,819 | 416,109 | ||||
| Gain on extinguishment of convertible debt | – | (247,283) | ||||
| Non-GAAP net income (loss) | 2,248,182 | (49,415) | ||||
| Earnings (loss) per ordinary share | 0.001 | (0.001) | ||||
| – Basic and diluted | ||||||
| Add: | ||||||
| Changes in fair value of financial instruments | – | – | ||||
| Gain on extinguishment of convertible debt | – | – | ||||
| Non-GAAP earnings (loss) per ordinary share – basic and diluted | 0.001 | (0.001) | ||||
- Allego Announces Framework Agreement with Kempower Delivering the Next Generation of High Power Charging Across Europe - July 2, 2025
- Akropolis Group Audit Committee Reappointed for a New Four-Year Term - July 2, 2025
- GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch - July 2, 2025
